Yip W, Hsiao W. 2015. What Drove the Cycles of Chinese Health System Reforms? Health Systems & Reform1: 52–61.
 Ramesh M, Wu X. 2009. Health policy reform in China: lessons from Asia. Social Science and Medicine68(12): 2256–2262.
 Hesketh T, Wei XZ. 1997. Health in China. From Mao to market reform. BMJ314: 1543
 Blumenthal D, Hsiao W. 2005. Privatization and its discontents—the evolving Chinese health care system. New England Journal of Medicine353: 1165–70.
 China National Health Development Research Center. 2009. China National Health Accounts Report. Beijing: Ministry of Health.
 Hu S, Tang S, Liu Y et al. 2008. Reform of how health care is paid for in China: challenges and opportunities. Lancet372: 1846–53.
 Tang S, Meng Q, Chen L et al. 2008. Tackling the challenges to health equity in China. Lancet 372: 1493–501.
 Eggleston K, Ling L, Qingyue M et al. 2008. Health service delivery in China: a literature review. Health Economics 17: 149–65.
 Yip W, Hsiao W, Meng Q et al. 2010. Realignment of incentives for health-care providers in China. Lancet375: 1120–30.
 Ding XY. 2014. Physician compensation report 2012–2013. China Health Human Resources 5: 74–75.
 Ministry of Health. 2013. China’s health statistics yearbook. Beijing: China Statistics Press.
 Lin JY, Cai F, Li Z. 2003. The China miracle: development strategy and economic reform. Beijing: Chinese University Press.
 Ge Y, Gong S. 2007. Chinese health care reform: problems, reasons and solutions. Beijing: China Development Publishing House.
 Li L. 2011. The challenges of healthcare reforms in China. Public Health125: 6–8.
 National Bureau of Statistics of China. 2007–13. China statistical yearbook. Beijing: China Statistics Press.
 Li Y, Xu J, Wang F et al. 2012. Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. Health Affairs31: 1075–82.
 He GX, VandenHof S, VanderWerf MJ et al. 2011. Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals. Clin Inf D52: e153-e6.
 Zhang T, Tang S, Jun G et al. 2007. Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health7: 19.
 Yip W, Hsiao W. 2008. The Chinese health system at a crossroads. Health Affairs27: 460–8.
 Chen Z. 2009. Launch of the health-care reform plan in China. Lancet373(9672): 1322–1324.
 Wu L, Sun Z, Shi Z. 2011. Public finance invests more than three trillion RMB in the health reform. Economic Information Daily. Beijing: Xinhua News Agency.
 Meng Q, Xu L, Zhang Y et al. 2012. Trends in access to health services and financial protection in China between 2003 and 2011: a cross- sectional study. Lancet379: 805–14.
 Yip W, Hsiao W, Chen W et al. 2012. Early appraisal of China’s huge and complex health-care reforms. Lancet 379: 833–42.
 Zhang Y, Ma Q, Chen Y et al. 2017. Effects of public hospital reform on inpatient expenditures in rural China. Health Economics 26: 421–430.
 Barber SL, Borowitz M, Bekedam H et al. 2014. The hospital of the future in China: China’s reform of public hospitals and trends from industrialized countries. Health Policy and Planning29: 367–78.
 Wagstaff A, Yip W, Lindelow M et al. 2009. China’s health system and its reform: a review of recent studies. Health Economics18(Suppl 2): S7–23.
 Ministry of health and other five Ministries. 2010. Guidance on the pilot reform of public hospitals. Beijing: China Legal Press.
 Mao W, Chen W. 2013. The Zero Mark-up Policy for essential medicines at primary level facilities. World Health Organization Report. https://www.who.int/health_financing/documents/Efficiency_health_systems…/en/, accessed 10 Aug, 2019.
 Mao W, Chen M, Chen W et al. 2013. Implementation of essential medicines policy at primary health care institutions. Chinese Health Resources16(2):91–92,125.
 Hu HM, Wu Y, Ye CY et al. 2013. The preliminary evaluation of county-level public hospitals reform. Chinese Journal of Hospital Administration29(5): 329–335.
 Wu C, Dai T, Yang Y. 2017. Comparative Study of Comprehensive Reform of the Pharmaceutical Price in Some Places in China. Chinese Hospital Management37: 1–4.
 Fu H, Li L, Li M et al. 2017. An evaluation of systemic reforms of public hospitals: the Sanming model in China. Health Policy and Planning32: 1135–45.
 Zhang H, Hu H, Wu C et al. 2015. Impact of China’s Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province. Plos One10: e0143130.
 Tang Y, Liu C, Liu J et al. 2018. Effects of County Public Hospital Reform on Procurement Costs and Volume of Antibiotics: A Quasi-Natural Experiment in Hubei Province, China. Pharmacoeconomics 36(8): 995–1004.
 Jiang S, Wu WM, Fang P. 2016. Evaluating the effectiveness of public hospital reform from the perspective of efficiency and quality in Guangxi, China. SpringerPlus5(1):1922.
 Shi X, Zhu D, Man X et al. 2019. “The biggest reform to China’s health system”: did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals? Health Policy and Planningpii: czz053. [Epub ahead of print]
 Pan J, Qin X, Hsieh CR. 2016. Is the pro-competition policy an effective solution for China’s public hospital reform? Health Economics Policy & Law11(4):337–57.
 Zhao D, Zhang Z. 2018. Qualitative analysis of direction of public hospital reforms in China. Frontiers of Medicine12(2):218–223.
 Fu H, Li L, Yip W. 2018. Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. Social Science & Medicine211:114–122.
 Tang W, Xie J, Lu Y et al. 2018. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing. Journal of Medical Economics21(4): 326–339.
 Liu X, Xu J, Yuan B et al. 2019. Containing medical expenditure: lessons from reform of Beijing public hospitals. BMJ365: l2369.
 Xiao Y, Zhao K, Bishai DM et al. 2013. Essential drugs policy in three rural counties in China: what does a complexity lens add? Social Science and Medicine93: 220–8.
 Yi H, Miller G, Zhang L et al. 2015. Intended and unintended consequences of China’s zero markup drug policy. Health Affairs 34: 1391–8.
 Stiglitz JE. 1989. Markets, market failures, and development. The American Economic Review79: 197–203.
 North DC, Weingast BR. 1989. Constitutions and commitment: the evolution of institutions governing public choice in seventeenth-century England. Journal of Economic History49: 803–32.
 Arrow KJ. 1969. The organization of economic activity: issues pertinent to the choice of market vs. nonmarket allocation. In: The analysis and evaluation of public expenditure: the PPB system. Joint Economic Committee, 91st Cong., 1st sess., vol. 1. Washington, DC: Government Printing Office, 59–73.
 Zhang H. 2013. The argument about the new health reform lines: government and market. The Reform and Open-up4: 9.
 Korolev A. 2014. Deliberative democracy nationwide?—evaluating deliberativeness of healthcare reform in China. Journal of Chinese Political Science19: 151–72.
 Ostrom V, Ostrom E. 1999. Public goods and public choices. In: McGinnis M (ed). Polycentricity and local public economies readings from the workshop in political theory and policy analysis. Ann Arbor: University of Michigan Press, 75–105.
 Hayek FA. 2013. The constitution of liberty: the definitive edition. New York: Routledge Press.
 Friedman M. 2002. Capitalism and freedom. Chicago: University of Chicago Press.
 McGuire TG. 2000. Physician agency. Handbook of Health Economics1: 461–536.
 Folland S, Goodman AC, Stano M. 2007. The economics of health and health Care. New Jersey: Prentice Hall.
 Reynolds L, McKee M. 2011. Serve the people or close the sale? Profit-driven overuse of injections and infusions in China’s market-based healthcare system. The International Journal of Health Planning and Management 26: 449–70.
 Chow GC. 2006. An economic analysis of health care in China. Princeton University.
 Hsiao W. 2014. Correcting past health policy mistakes. Daedalus143: 53–68.
 Wagstaff A, Bales S. 2012. The impacts of public hospital autonomization: evidence from a quasi-natural experiment. World Bank policy research working paper. https://elibrary.worldbank.org/doi/abs/10.1596/1813–9450–6137, accessed 11 Aug 2019.
 Jian W, Lu M, Chan KY et al. 2015. Payment Reform Pilot in Beijing Hospitals Reduced Expenditures And Out-Of-Pocket Payments Per Admission. Health Affairs34: 1745–52.
 Danzon P, Towse A, Mestre‐Ferrandiz J. 2015. Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context. Health Economics 24: 294–301.
 Horwitz JR. 2005. Making profits and providing care: Comparing nonprofit, for-profit, and government hospitals. Health Affairs 24(3): 790–801. PMID: 15886174
 Adam T, Hsu J, de Savigny D et al. 2012. Evaluating health systems strengthening interventions in low-income and middle-income countries: are we asking the right questions? Health Policy Plan 27(Suppl 4): iv9–19.
 Preker AS, Harding A. 2003. A conceptual framework for the organizational reforms of hospitals. In Harding A, Preker AS (eds) Innovations in Health Service Delivery: The Corporatization of Public Hospitals. Washington, DC: World Bank, 23–78.